Biology of Blood and Marrow Transplantation
Volume 14, Issue 12 , Pages 1323-1333 , December 2008

Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT): A Report from The Center For International Blood & Marrow Transplant Research (CIBMTR)

  • Hillard M. Lazarus

      Affiliations

    • University Hospitals Case Medical Center, Cleveland, Ohio
    • Corresponding Author InformationCorrespondence and reprint requests: Hillard M. Lazarus, MD, Department of Medicine, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106.
    • ,
  • Jeanette Carreras

      Affiliations

    • Lymphoma Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, Wisconsin
    • ,
  • Christian Boudreau

      Affiliations

    • University of Waterloo, Waterloo, Ontario, Canada
    • ,
  • Fausto R. Loberiza Jr.

      Affiliations

    • University of Nebraska Medical Center, Omaha, Nebraska
    • ,
  • James O. Armitage

      Affiliations

    • University of Nebraska Medical Center, Omaha, Nebraska
    • ,
  • Brian J. Bolwell

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • César O. Freytes

      Affiliations

    • University of Texas Health Science Center, San Antonio, Texas
    • ,
  • Robert Peter Gale

      Affiliations

    • Center for Advanced Studies in Leukemia, Los Angeles, Californai
    • ,
  • John Gibson

      Affiliations

    • Royal Prince Alfred Hospital, Camperdown, Australia
    • ,
  • Gregory A. Hale

      Affiliations

    • St. Jude Children Research Center, Memphis, Tennessee
    • ,
  • David J. Inwards

      Affiliations

    • Mayo Clinic, Rochester, Minnesota
    • ,
  • Charles F. LeMaistre

      Affiliations

    • Texas Transplant Institute, San Antonio, Texas
    • ,
  • Dipnarine Maharaj

      Affiliations

    • South Florida Bone Marrow Stem Cell Institute, Boynton Beach, Florida
    • ,
  • David I. Marks

      Affiliations

    • Bristol Children's Hospital, Bristol, United Kingdom
    • ,
  • Alan M. Miller

      Affiliations

    • Tulane University Medical Center, New Orleans, Louisiana
    • ,
  • Santiago Pavlovsky

      Affiliations

    • Fundaleu, Buenos Aires, Argentina
    • ,
  • Harry C. Schouten

      Affiliations

    • University Hospitals Maastricht, Maastricht, The Netherlands
    • ,
  • Koen van Besien

      Affiliations

    • University of Chicago, Chicago, Illinois
    • ,
  • Julie M. Vose

      Affiliations

    • University of Nebraska Medical Center, Omaha, Nebraska
    • ,
  • Jacob D. Bitran

      Affiliations

    • Advocate Lutheran General Hospital, Park Ridge, Illinois
    • ,
  • Issa F. Khouri

      Affiliations

    • MD Anderson Cancer Research Center, Houston, Texas
    • ,
  • Philip L. McCarthy

      Affiliations

    • Roswell Park Cancer Institute, Buffalo, New York
    • ,
  • Hongmei Yu

      Affiliations

    • Shanxi Medical University, People's Republic of China
    • ,
  • Philip Rowlings

      Affiliations

    • Newcastile Mater Hospital, Waratah, Australia
    • ,
  • Derek S. Serna

      Affiliations

    • Lymphoma Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, Wisconsin
    • ,
  • Mary M. Horowitz

      Affiliations

    • Lymphoma Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, Wisconsin
    • ,
  • J. Douglas Rizzo

      Affiliations

    • Lymphoma Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, Wisconsin

Received 15 July 2008 ,Accepted 12 September 2008.

  • Image Result

    Cumulative incidence of TRM and relapse after autologous HCTs for follicular grade I/II NHL patients aged <55 years versus ≥55 years.

    Cumulative incidence of TRM and relapse after autologous HCTs for follicular grade I/II NHL patients aged <55 years versus ≥55 years.

  • Image Result

    Cumulative incidence of DFS and OS after autologous HCTs for follicular grade I/II NHL patients aged <55 years versus ≥55 years.

    Cumulative incidence of DFS and OS after autologous HCTs for follicular grade I/II NHL patients aged <55 years versus ≥55 years.

  • Image Result

    Cumulative incidence of TRM and relapse after autologous HCTs for follicular grade III/diffuse large B cell/immunoblastic NHL patients aged <55 years versus ≥55 years.

    Cumulative incidence of TRM and relapse after autologous HCTs for follicular grade III/diffuse large B cell/immunoblastic NHL patients aged <55 years versus ≥55 years.

  • Image Result

    Cumulative incidence of DFS and OS after autologous HCTs for follicular grade III/diffuse large B cell/immunoblastic NHL patients aged <55 years versus ≥55 years.

    Cumulative incidence of DFS and OS after autologous HCTs for follicular grade III/diffuse large B cell/immunoblastic NHL patients aged <55 years versus ≥55 years.

 Financial disclosure: See Acknowledgments on page 1332.

PII: S1083-8791(08)00398-4

doi: 10.1016/j.bbmt.2008.09.008

Biology of Blood and Marrow Transplantation
Volume 14, Issue 12 , Pages 1323-1333 , December 2008

Article Tools

* Image Usage & Resolution